1 / 4

Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema Makani H et al. Am

Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema Makani H et al. Am J Med. 2011;124:128-135,. METHOD:

csilla
Download Presentation

Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema Makani H et al. Am

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edemaMakani H et al. Am J Med. 2011;124:128-135, METHOD: • A MEDLINE/COCHRANE search for randomised controlled trials (RCT) in patients with hypertension, comparing calcium channel blocker (CCB) monotherapy with CCB/renin angiotensin system blocker combination conducted from 1980. • RCTs reporting the incidence of peripheral edema or withdrawal of patients because of edema and total sample size more than 100 were included in this analysis. • 25 RCTs with 17,206 patients (mean age 56 years, 55% were men) and a mean duration of 9.2 weeks. .

  2. Combining RAAS inhibitors with CCB decreases edema incidence/withdrawal rates with CCB Percentage CCB = calcium channel blocker; RAS = renin-angiotensin system *p<0.0001 Makani H et al. Am J Med. 2011;124:128-135

  3. ACE inhibitors are more efficaciousthanARBs in reducing CCB-associated edema P=0.0001 P<0.00001 Makani H et al. Am J Med. 2011;124:128-135

  4. Clinical significance Makani H et al. Am J Med. 2011;124:128-135. The combination of RAAS inhibitors with calcium channel blockers (CCB) reduces the incidence by 38% and withdrawal rate due to peripheral edema by 62% when compared with calcium channel blocker monotherapy. ACE inhibitors were significantly more efficacious than ARBs in reducing the incidence of CCB-associated peripheral edema by 54% and 24%, respectively (P<0.0001), Aliskiren did not show significant reduction of CCB-associated cough.

More Related